The AJMC® Asthma compendium is a comprehensive resource for clinical news and expert insights for the chronic lung disease.

Dupilumab Reduces OCS Dosage, Improves Lung Function for Asthma, CRSwNP

May 22nd 2022, 3:15pm


Dupilumab was associated with reductions in exacerbations and oral corticosteroids (OCS) dosage, as well as improved lung function, in patients with OCS-dependent asthma with and without comorbid chronic rhinosinusitis with nasal polyps.

Study: In Severe Asthma, Benefits of At-Home Biologics Outweigh Disadvantages

May 17th 2022, 6:21pm


A survey of patients and health care providers found both groups favor at-home administration of biologics when possible.

Dupilumab Improves Lung Function, Asthma Attacks in Children With Atopic Comorbidities

May 16th 2022, 4:30pm


Dupilumab improved lung function and reduced severe asthma exacerbation rates in children with moderate to severe asthma with or without atopic comorbidities.

Biologics Provide Opportunity to Manage Moderate to Severe Pediatric Asthma, Improve QOL

May 13th 2022, 5:15pm


Pediatric patients with asthma and their caregivers are faced with significant health and cost burdens, and biologics provide an opportunity to improve quality of life and asthma control, according to a panel of experts.

Improved Sense of Smell Achieved With Biologics for CRS With Nasal Polyps, Asthma

May 12th 2022, 12:20pm


Patients with comorbid chronic rhinosinusitis (CRS) with nasal polyps and severe asthma reported significant improvement in their sense of smell when treated with the biologics omalizumab, mepolizumab, reslizumab, or benralizumab, with no significant differences observed between the treatment groups.

Certain Component of Particulate Matter May Have Harmful Implications for Asthma

May 6th 2022, 4:04pm


In this new study, researchers wrote of the implications that detailed an association between asthma and exposure to particulate matter less than or equal to 2.5 mcm.

Clinical Improvement of AERD Achieved With Dupilumab Use for Asthma, CRS With Nasal Polyps

May 3rd 2022, 6:25pm


Patients with aspirin-exacerbated respiratory disease (AERD) who initiated treatment with dupilumab as an add-on asthma or chronic rhinosinusitis with nasal polyps therapy reported rapid clinical improvement that was sustained after 3 months.

Adding Inhaled Glucocorticoid May Relieve Asthma Burden in Black, Latinx Patients

April 30th 2022, 7:35pm


Using an inhaled glucocorticoid in addition to usual care reduced the rate of severe asthma exacerbations and improved other markers of disease severity.

Adults With Asthma Have Higher Risk of Future Obesity, New Study Says

April 27th 2022, 11:01pm


The study is the first to find an association between adults with asthma and the risk of obesity developing later.

Study: Oxidative Stress Underlies Asthma Risk Associated With Air Pollutant Exposure

April 23rd 2022, 1:14pm


Researchers outlined 3 mechanisms in which PM2.5 induces asthma, all of which they say are tied to oxidative stress balance.